Rockwell Medical Technologies (NASDAQ:RMTI) is one of today's notable stocks in decline, down 1.7% to $6.90. The S&P is currently trading fractionally higher to 1,497 and the Dow Jones Industrial Average is trading fractionally higher to 13,847.
Rockwell Medical Technologies, Inc. manufactures, markets, and delivers dialysis solutions, powders, and ancillary products to hemodialysis providers. The Company offers Dri-State Dry Acid, Liquid Acid, SteriLyte Liquid Bicarbonate, Powder Bicarbonate, and ancillary dialysis items. Rockwell's products are used to cleanse a patient's blood and replace nutrients in the bloodstream.
In the past 52 weeks, Rockwell Medical Technologies share prices have been bracketed by a low of $5.18 and a high of $16.91 and are now at $6.90, 33% above that low price. In the last five trading sessions, the 50-day moving average (MA) has climbed 0.6% while the 200-day MA has slid 0.4%.
Rockwell Medical Technologies (NASDAQ:RMTI) has potential upside of 127.1% based on a current price of $6.90 and analysts' consensus price target of $15.67. The stock should find initial resistance at its 50-day moving average (MA) of $7.31 and further resistance at its 200-day MA of $8.16.
